<DOC>
	<DOC>NCT00131300</DOC>
	<brief_summary>This clinical study is to evaluate the safety and efficacy of Synvisc in patients with symptomatic shoulder osteoarthritis (OA). Patients will be given Synvisc, with the possible administration of a second injection where insufficient symptomatic pain relief was experienced during the 3 month follow up period.</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Musculoskeletal Diseases</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Patients with symptomatic OA pain of shoulder (glenohumeral) Patients with current or prior conditions or treatment that would impede measurement of efficacy or safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Osteoarthritis of the shoulder</keyword>
	<keyword>Musculoskeletal</keyword>
</DOC>